Case Studies In FDA's Regulatory Interpretation Of Clinical Trials
Executive Summary
For more than 15 years, the Pink Sheet's Drug Review Profile series has looked closely at FDA approval documents, providing a long view of the pitfalls and pitches presented in the NEJM series on interpreting clinical trial results.